12 results
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... anticoagulant agents ... (DOACS + Warfarin ... #DOAC #Dosing #Oral ... #Table #Pharmacology
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
Direct-acting oral ... ) for VTE treatment ... Table #DOAC ... VTE #Management #Pharmacology ... #Comparison #Table
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
Tobacco Cessation Treatment ... ) #Pharmacology ... Cessation #Therapy #Comparison ... #Table #Agents ... #Dosing
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
including tips for using ... dosage forms and conversion ... #pharmacology #antibiotics ... #medications #table ... #treatment #drugs
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
are usually the drugs ... #pharmacology #comparison ... #treatment #medications ... #dosing #drugs ... #table #pharmacotherapy
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... cirrhosis) • Oral ... • Neuropathic agents ... #Table #Ladder ... #guide #comparison
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
direct acting oral ... clearance (calculated using ... interruption per treatment ... table ... #pharmacology #
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Individualized Treatment ... agents preferred ... MDRTB #management #Treatment ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... agents in the acute ... dose of a given drug ... the timing and dosing ... ticagrelor #prasugrel #pharmacology
Pharmacologic Options for Hypercalcemia Associated with Cancer
Rehydration with NS followed by loop diuretics
 • IV normal
diuretics • IV normal ... Inhibits vitamin D conversion ... medications #management #drugs ... #treatment #pharmacology ... #table